These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26923396)

  • 1. Emerging Potential of Natural Products as an Alternative Strategy to Pharmacological Agents Used Against Metabolic Disorders.
    Dias TR; Bernardino RL; Meneses MJ; Sousa M; Sá R; Alves MG; Silva BM; Oliveira PF
    Curr Drug Metab; 2016; 17(6):582-97. PubMed ID: 26923396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A natural product solution to aging and aging-associated diseases.
    Yang C; Zhang W; Dong X; Fu C; Yuan J; Xu M; Liang Z; Qiu C; Xu C
    Pharmacol Ther; 2020 Dec; 216():107673. PubMed ID: 32926934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders.
    Waltenberger B; Mocan A; Šmejkal K; Heiss EH; Atanasov AG
    Molecules; 2016 Jun; 21(6):. PubMed ID: 27338339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions.
    Pittala V; Vanella L; Salerno L; Romeo G; Marrazzo A; Di Giacomo C; Sorrenti V
    Curr Med Chem; 2018; 25(13):1577-1595. PubMed ID: 28618991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF21-based pharmacotherapy--potential utility for metabolic disorders.
    Gimeno RE; Moller DE
    Trends Endocrinol Metab; 2014 Jun; 25(6):303-11. PubMed ID: 24709036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural molecules for the therapy of hyperandrogenism and metabolic disorders in PCOS.
    Cappelli V; Musacchio MC; Bulfoni A; Morgante G; De Leo V
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):15-29. PubMed ID: 28724177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in the Development of Pharmaceutical Agents for Metabolic Disorders: A Computational Perspective.
    Janardhan S; Dubovskaja V; Lagunin A; Rao BV; Sastry GN; Poroikov V
    Curr Med Chem; 2018; 25(39):5432-5463. PubMed ID: 28969540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?
    Carratù MR; Signorile A; De Rasmo D; Reale A; Vacca A
    Curr Med Chem; 2016; 23(38):4286-4296. PubMed ID: 27758717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids and Metabolic Disorders.
    Gatta-Cherifi B; Cota D
    Handb Exp Pharmacol; 2015; 231():367-91. PubMed ID: 26408168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-Target Drugs Against Metabolic Disorders.
    Scotti L; Monteiro AFM; de Oliveira Viana J; Mendonça Junior FJB; Ishiki HM; Tchouboun EN; Santos R; Scotti MT
    Endocr Metab Immune Disord Drug Targets; 2019; 19(4):402-418. PubMed ID: 30556507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Medicinal Chemistry of Natural and Semisynthetic Compounds against Parkinson's and Huntington's Diseases.
    Zanforlin E; Zagotto G; Ribaudo G
    ACS Chem Neurosci; 2017 Nov; 8(11):2356-2368. PubMed ID: 28862431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
    Vemuri VK; Janero DR; Makriyannis A
    Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds.
    Zanforlin E; Zagotto G; Ribaudo G
    Curr Med Chem; 2017 Nov; 24(34):3749-3773. PubMed ID: 28707586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural products, micronutrients, and nutraceuticals for the treatment of depression: A short review.
    Nabavi SM; Daglia M; Braidy N; Nabavi SF
    Nutr Neurosci; 2017 Apr; 20(3):180-194. PubMed ID: 26613119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations.
    Ezuruike UF; Prieto JM
    J Ethnopharmacol; 2014 Sep; 155(2):857-924. PubMed ID: 24929108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traditional and alternative natural therapeutic products used in the treatment of respiratory tract infectious diseases in the eastern Catalan Pyrenees (Iberian Peninsula).
    Rigat M; Vallès J; Iglésias J; Garnatje T
    J Ethnopharmacol; 2013 Jul; 148(2):411-22. PubMed ID: 23612419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of complementary/integrative nutritional therapies during cancer treatment: implications in clinical practice.
    Kumar NB; Hopkins K; Allen K; Riccardi D; Besterman-Dahan K; Moyers S
    Cancer Control; 2002; 9(3):236-43. PubMed ID: 12060821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnobotany and herbal medicine in modern complementary and alternative medicine: An overview of publications in the field of I&C medicine 2001-2013.
    Popović Z; Matić R; Bojović S; Stefanović M; Vidaković V
    J Ethnopharmacol; 2016 Apr; 181():182-92. PubMed ID: 26807912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.